BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21531120)

  • 21. A novel point mutation of the FALDH gene in a Japanese family with Sjögren-Larsson syndrome.
    Aoki N; Suzuki H; Ito K; Ito M
    J Invest Dermatol; 2000 May; 114(5):1065-6. PubMed ID: 10792573
    [No Abstract]   [Full Text] [Related]  

  • 22. Interlamellar lipid differences between normal and psoriatic stratum corneum.
    Motta S; Sesana S; Monti M; Giuliani A; Caputo R
    Acta Derm Venereol Suppl (Stockh); 1994; 186():131-2. PubMed ID: 8073812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum of mutations and sequence variants in the FALDH gene in patients with Sjögren-Larsson syndrome.
    Sillén A; Anton-Lamprecht I; Braun-Quentin C; Kraus CS; Sayli BS; Ayuso C; Jagell S; Küster W; Wadelius C
    Hum Mutat; 1998; 12(6):377-84. PubMed ID: 9829906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sjögren-larsson syndrome and crystalline maculopathy associated with a novel mutation.
    Jean-François E; Low JY; Gonzales CR; Sarraf D
    Arch Ophthalmol; 2007 Nov; 125(11):1582-3. PubMed ID: 17998529
    [No Abstract]   [Full Text] [Related]  

  • 25. Ceramide profiling of stratum corneum in Sjögren-Larsson syndrome.
    Arai A; Takeichi T; Wakamoto H; Sassa T; Ito Y; Murase Y; Ogi T; Akiyama M; Kihara A
    J Dermatol Sci; 2022 Sep; 107(3):114-122. PubMed ID: 35973883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome.
    Willemsen MA; IJlst L; Steijlen PM; Rotteveel JJ; de Jong JG; van Domburg PH; Mayatepek E; Gabreëls FJ; Wanders RJ
    Brain; 2001 Jul; 124(Pt 7):1426-37. PubMed ID: 11408337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sjögren-Larsson syndrome: biochemical defects and follow up in three cases.
    Auada MP; Taube MB; Collares EF; Tanaka AM; Cintra ML
    Eur J Dermatol; 2002; 12(3):263-6. PubMed ID: 11978568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sjögren-Larsson syndrome: novel mutations in the ALDH3A2 gene in a French cohort.
    Sarret C; Rigal M; Vaurs-Barrière C; Dorboz I; Eymard-Pierre E; Combes P; Giraud G; Wanders RJ; Afenjar A; Francannet C; Boespflug-Tanguy O
    J Neurol Sci; 2012 Jan; 312(1-2):123-6. PubMed ID: 21872273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sjögren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2.
    Carney G; Wei S; Rizzo WB
    Hum Mutat; 2004 Aug; 24(2):186. PubMed ID: 15241804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes.
    Davis K; Holden KR; S'Aulis D; Amador C; Matheus MG; Rizzo WB
    J Child Neurol; 2013 Oct; 28(10):1259-65. PubMed ID: 23034980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compound heterozygous mutations in the
    Liu YD; Lin HJ; Li CY; Sun GF; Hu XB; Ma MY; Sun Y; Feng BZ; Li QB; Kong QX
    Int J Neurosci; 2020 Nov; 130(11):1156-1160. PubMed ID: 31944864
    [No Abstract]   [Full Text] [Related]  

  • 32. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.
    De Laurenzi V; Rogers GR; Hamrock DJ; Marekov LN; Steinert PM; Compton JG; Markova N; Rizzo WB
    Nat Genet; 1996 Jan; 12(1):52-7. PubMed ID: 8528251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzymatic diagnosis of Sjögren-Larsson syndrome using electrospray ionization mass spectrometry.
    Sanders RJ; Ofman R; Dekker C; Kemp S; Wanders RJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):451-5. PubMed ID: 19124283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype and phenotype variability in Sjögren-Larsson syndrome.
    Weustenfeld M; Eidelpes R; Schmuth M; Rizzo WB; Zschocke J; Keller MA
    Hum Mutat; 2019 Feb; 40(2):177-186. PubMed ID: 30372562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel ALDH3A2 heterozygous mutations are associated with defective lamellar granule formation in a Japanese family of Sjögren-Larsson syndrome.
    Shibaki A; Akiyama M; Shimizu H
    J Invest Dermatol; 2004 Dec; 123(6):1197-9. PubMed ID: 15610535
    [No Abstract]   [Full Text] [Related]  

  • 36. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
    Rizzo WB; Craft DA; Somer T; Carney G; Trafrova J; Simon M
    J Lipid Res; 2008 Feb; 49(2):410-9. PubMed ID: 17971613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incomplete Sjögren-Larsson syndrome in two Japanese siblings?
    Willemsen MA; Rotteveel JJ; Steijlen PM; Wanders RJ
    Dermatology; 1999; 199(2):187-8. PubMed ID: 10559596
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid composition of the superficial stratum corneum cells of pig epidermis.
    Gray GM; White RJ; Williams RH; Yardley HJ
    Br J Dermatol; 1982 Jan; 106(1):59-63. PubMed ID: 7059505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, biochemical, and genetic aspects of Sjögren-Larsson syndrome.
    Cho KH; Shim SH; Kim M
    Clin Genet; 2018 Apr; 93(4):721-730. PubMed ID: 28543186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired Skin Barrier Function Due to Reduced ω-
    Nojiri K; Fudetani S; Arai A; Kitamura T; Sassa T; Kihara A
    Mol Cell Biol; 2021 Sep; 41(10):e0035221. PubMed ID: 34370553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.